Integer Holdings Co. (NYSE:ITGR – Free Report) – Stock analysts at Zacks Research increased their Q4 2024 earnings per share (EPS) estimates for shares of Integer in a research report issued on Tuesday, January 7th. Zacks Research analyst D. Dey now expects that the medical equipment provider will earn $1.46 per share for the quarter, up from their prior forecast of $1.45. The consensus estimate for Integer’s current full-year earnings is $5.33 per share. Zacks Research also issued estimates for Integer’s Q3 2026 earnings at $1.65 EPS.
A number of other equities analysts have also recently weighed in on ITGR. Truist Financial upped their price objective on shares of Integer from $147.00 to $163.00 and gave the company a “buy” rating in a research report on Wednesday, December 11th. Citigroup upped their price objective on shares of Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a research report on Wednesday, December 11th. Bank of America increased their price target on shares of Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a research report on Tuesday, October 1st. Benchmark increased their price target on shares of Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a research report on Monday, October 21st. Finally, Wells Fargo & Company reaffirmed an “overweight” rating and set a $160.00 price target on shares of Integer in a research report on Tuesday, December 3rd. One investment analyst has rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $145.44.
Integer Stock Up 0.5 %
Shares of NYSE ITGR opened at $133.83 on Friday. The company has a current ratio of 3.28, a quick ratio of 2.09 and a debt-to-equity ratio of 0.67. The stock has a fifty day moving average price of $135.88 and a 200 day moving average price of $127.94. The company has a market cap of $4.49 billion, a P/E ratio of 41.31, a P/E/G ratio of 1.99 and a beta of 1.12. Integer has a 12-month low of $94.56 and a 12-month high of $142.76.
Integer (NYSE:ITGR – Get Free Report) last announced its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.07. Integer had a return on equity of 11.63% and a net margin of 6.70%. The firm had revenue of $431.42 million during the quarter, compared to the consensus estimate of $440.59 million. During the same period in the prior year, the firm earned $1.27 EPS. The firm’s quarterly revenue was up 8.7% compared to the same quarter last year.
Hedge Funds Weigh In On Integer
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Arizona State Retirement System boosted its stake in shares of Integer by 2.4% during the 2nd quarter. Arizona State Retirement System now owns 9,378 shares of the medical equipment provider’s stock valued at $1,086,000 after buying an additional 219 shares during the period. Quest Partners LLC raised its holdings in shares of Integer by 3,688.9% during the 2nd quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider’s stock valued at $39,000 after purchasing an additional 332 shares in the last quarter. American Century Companies Inc. raised its holdings in shares of Integer by 249.7% during the 2nd quarter. American Century Companies Inc. now owns 15,710 shares of the medical equipment provider’s stock valued at $1,819,000 after purchasing an additional 11,218 shares in the last quarter. Zions Bancorporation N.A. raised its holdings in shares of Integer by 4.6% during the 2nd quarter. Zions Bancorporation N.A. now owns 22,084 shares of the medical equipment provider’s stock valued at $2,557,000 after purchasing an additional 964 shares in the last quarter. Finally, Westover Capital Advisors LLC raised its holdings in shares of Integer by 18.2% during the 2nd quarter. Westover Capital Advisors LLC now owns 2,704 shares of the medical equipment provider’s stock valued at $313,000 after purchasing an additional 417 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.
About Integer
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Featured Stories
- Five stocks we like better than Integer
- The Risks of Owning Bonds
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- Market Cap Calculator: How to Calculate Market Cap
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- What Are Earnings Reports?
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.